The CAMBRIA-2 clinical trial is an international study which aims to improve treatments for patients with intermediate to high-risk breast cancer. The study aims to recruit 6,000 people worldwide, who have oestrogen receptor-positive, HER2 negative breast cancer.
----------------------------------------------------------------
Breast Cancer Trials is a group of world-leading breast cancer doctors and researchers based in Australia and New Zealand committed to exploring and finding better treatments for people affected by breast cancer through clinical trials research.

Please like this video then visit www.breastcancertrials.org.au to find out more about our current breast cancer clinical trials that may be suitable for you, and ways in which you can help support breast cancer research.

----------------------------------------------------------------

SUBSCRIBE TO OUR YOUTUBE CHANNEL
   / @breastcancertrials  

LET'S CONNECT
Email ►[email protected]
Tel 1800 423 444
WWW ► http://www.breastcancertrials.org.au
Linkedin ►   / 5057154  
Twitter ►   / bctrialsanz  
Facebook ►   / breastcancertrials  
Instagram ►   / breastcancertrials